• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550400-23
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Health Effect - Clinical Codes Heart Failure/Congestive Heart Failure (4446); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/09/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that the procedure was to treat an unspecified lesion.Post stent implantation of a xience stent, worsening heart failure was noted.This was resolved in an unspecified manner.No additional information was provided.
 
Additional Manufacturer Narrative
This complaint has been captured as a non-complaint product experience as there was no device malfunction or patient effect associated with the device; thus, investigation is not required.H6: health effect - clinical code 4446 - removed.H6: health effect - impact code 4614 - removed.H6: medical device problem code 2993 - removed.
 
Event or Problem Description
Subsequent to the initial medwatch report, the following information was received: it was reported that on (b)(6) 2020, the patient presented with an acute st elevation myocardial infarction (mi), diagnosed as acute coronary syndrome (acs).Low left heart function of about 30% was noted and heart failure was diagnosed.Medications were administered and an aortic balloon pump was placed.Additionally, stenosis was noted in the left anterior descending (lad) coronary artery and a 4.0x23mm xience sierra stent was implanted.Per the physician, the patient condition was related to onset of acs and not to the implantation of the stent.Stent implantation was to treat the acs.On 09/30/2020, the condition resolved and the patient was discharged from the hospital.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P031)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14838255
Report Number2024168-2022-06942
Device Sequence Number14048910
Product Code NIQ
UDI-Device Identifier08717648227516
UDI-Public08717648227516
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Study,Company Representative,Distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number1550400-23
Device Catalogue Number1550400-23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/03/2022
Supplement Date Received by Manufacturer07/07/2022
Initial Report FDA Received Date06/27/2022
Supplement Report FDA Received Date07/27/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age59 YR
Patient SexMale
Patient Weight75 KG
-
-